On Friday, Shares of Amkor Technology, Inc. (NASDAQ:AMKR), lost -1.68% to $5.28.
Amkor Technology, declared that it will take part in the following investor conferences:
- Deutsche Bank Technology Conference on Thursday, September 17, 2015. Amkor’s presentation will occur at 11:00 am Pacific Time (2:00 pm Eastern Time) at The Cosmopolitan of Las Vegas in Las Vegas, NV.
Amkor Technology, Inc. provides outsourced semiconductor packaging and test services in the United States, China, Ireland, Japan, Singapore, Taiwan, Thailand, and internationally.
Shares of Centene Corp (NYSE:CNC), inclined 2.47% to $63.43, during its last trading session.
Centene Corporation, declared that its Georgia partner, Peach State Health Plan, was one of the Care Administration Organizations selected to serve Medicaid recipients in Georgia. The new contract is predictable to start on July 1, 2016, pending regulatory approvals.
Under the new contract, Peach State Health Plan will be one of four plans serving over 1.3 million members enrolled in the Georgia Families, PeachCare for Kids and Planning for Healthy Babies programs.
“Peach State is proud to continue our nearly 10-year partnership with the Department of Community Health to provide comprehensive care to Georgia residents,” said Patrick Healy, Chief Executive Officer for Peach State Health Plan. “We are looking forward to building on the relationships that we have formed with local providers and community groups to make a positive impact on the health of our members in a cost-effective manner for the state.”
Centene Corporation operates as a diversified, multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. It operates in two segments, Managed Care and Specialty Services.
At the end of Friday’s trade, Shares of Entergy Corporation (NYSE:ETR), gained 1.05% to $62.68.
For its integral role that resulted in nearly $14.4 billion of capital investment and the creation of over 7,200 new jobs in its service territory, Entergy Corporation (ETR) has been named one of the nation’s Top 10 utilities in economic development for 2014 by Site Selection magazine.
“We’re honored to be recognized by Site Selection magazine as one of the top utilities for the eighth successive year,” said Mark Kleehammer, vice president of Entergy’s Business Development Services. “Utilities must actively take part in the economic development process and work closely with state agencies and local communities to influence the outcome. Entergy has and will continue to support our customers and our state and local partners to highlight the region’s highly competitive utility rates, superior infrastructure, constructive business climate, and able workforce in order to continue the region’s robust economic expansion.”
Criteria used by Site Selection to choose the top 10 comprises the utility’s use of innovative programs and incentives for business and the utility’s own job-creating infrastructure and facility investment trends.
Entergy Corporation, together with its auxiliaries, engages in the electric power production and retail electric distribution operations in the United States. It operates in two segments, Utility and Entergy Wholesale Commodities.
Finally, Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN), ended its last trade with 0.52% gain, and closed at $7.77.
Achillion Pharmaceuticals, declared that Milind Deshpande, Ph.D., President and Chief Executive Officer of Achillion, will present a corporate overview at two forthcoming investor conference:
- Morgan Stanley Global Healthcare Conference on Thursday, September 17, 2015 at 10:35 a.m. ET at The Grand Hyatt Hotel in New York, NY.
Achillion Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes anti-infective drug therapies in the United States and internationally. It focuses on developing combination therapies for the treatment of chronic hepatitis C (HCV) infection and drug-resistant bacterial infections.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
